semaglutide kidney stones Are A Side Effect Of Ozempic GLP-1 and Kidney Stones: Risk

Why You'll Love it

The asserted patent is U.S

A March 2026 study from Washington University School of Medicine, published in BMJ Medicine, found that stopping GLP-1 medications can rapidly erase those cardiac benefits

Additionally, nearly 60% of European adults are overweight or obese, increasing the risk of type 2 diabetes and metabolic complications

It also helps with insurer credentialing and answering the inevitable Is this within your scope? questions from hospital committees or licensing boards

The added thermogenic and hepatic-lipid effect is hypothesised to account for the larger weight-loss magnitude observed in Phase 2 compared with dual GIP/GLP-1 agonism [1]